[1. Ros PR, Erturk SM. Malignant tumors of the liver. In: Gore RM, Levine MS. Gastrointestinal radiology, 3rd ed. Philadelphia:Saunders Elsevier; 2008. p. 1624-33.10.1016/B978-1-4160-2332-6.50094-4]Search in Google Scholar
[2. Hanna RF, Aguirre DA, Kased N, Emery SC, Peterson MR, Sirlin CB. Cirrhosis-associated hepatocellular nodules: correlation of histopathologic and MR imaging features. Radiographics. 2008; 28:747-69.10.1148/rg.283055108]Open DOISearch in Google Scholar
[3. Hussain SM, Semelka RC, Mitchell DG. MR imaging of hepatocellular carcinoma. Magn Reson Imaging Clin N Am. 2002; 10:31-52.10.1016/S1064-9689(03)00048-5]Search in Google Scholar
[4. Yamashita Y, Mitsuzaki K, Yi T, Ogata I, Nishiharu T, Urata J, et al. Small hepatocellular carcinoma in patients with chronic liver damage: prospective comparison of detection with dynamic MR imaging and helical CT of the whole liver. Radiology. 1996; 200:79-84.10.1148/radiology.200.1.86579488657948]Search in Google Scholar
[5. Colli A, Fraquelli M, Casazza G, Massironi S, Colucci A, Conte D, et al. Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review. Am J Gastroenterol. 2006; 101:513-23.10.1111/j.1572-0241.2006.00467.x16542288]Search in Google Scholar
[6. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005; 42:1208-36.10.1002/hep.2093316250051]Open DOISearch in Google Scholar
[7. Kadoya M, Matsui O, Takashima T, Nonomura A. Hepatocellular carcinoma: Correlation of MR imaging and histopathologic findings. Radiology. 1992; 183: 819-25.10.1148/radiology.183.3.13166221316622]Search in Google Scholar
[8. Stevens WR, Johnson CD, Stephens DH, Batts KP. CT findings in hepatocellular carcinoma: correlation of tumor characteristics with causative factors, tumor size, and histologic tumor grade. Radiology. 1994; 191: 531-7.10.1148/radiology.191.2.81533358153335]Search in Google Scholar
[9. Willatt JM, Hussain HK, Adusumilli S, Marrero JA. MR imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. Radiology. 2008; 247:311-30.10.1148/radiol.247206133118430871]Search in Google Scholar
[10. Kelekis NL, Semelka RC, Worawattanakul S, Lange EE, Ascher SM, Ahn IO, et al. Hepatocellular carcinoma in North America: A multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial Gadolinium-enhanced gradient-echo images. Am J Roentgenol. 1998; 170:1005-13.10.2214/ajr.170.4.95300519530051]Search in Google Scholar
[11. Lutz AM, Willmann JK, Goepfert K, Marincek B, Weishaupt D. Hepatocellular carcinoma in cirrhosis: Enhancement patterns at dynamic Gadolinium- and Superparamagnetic iron oxide-enhanced T1-weighted MR imaging. Radiology. 2005; 237:520-8.10.1148/radiol.237204118316192317]Search in Google Scholar
[12. Matsui O. Imaging of multistep human hepatocarcinogenesis by CT during intra-arterial contrast injection. Intervirology. 2004; 47:3-5.10.1159/00007847815383735]Search in Google Scholar
[13. Gabata T, Matsui O, Kadoya M, Yoshikawa J, Ueda K, Kawamori Y, et al. Delayed MR imaging of the liver: correlation of delayed enhancement of hepatic tumors and pathologic appearance. Abdom Imaging. 1998; 23: 309-13.10.1007/s0026199003479569304]Open DOISearch in Google Scholar
[14. Mahfouz AE, Hamm B, Wolf KJ. Dynamic gadopentetate dimeglumine-enhanced MR imaging of hepatocellular carcinoma. Eur J Radiol. 1993; 3:453-8.10.1007/BF00221423]Search in Google Scholar
[15. Freeny PC, Baron RL, Teefey SA. Hepatocellular carcinoma: reduced frequency of typical findings with dynamic contrast-enhanced CT in a non-Asian population. Radiology. 1992; 182:143-8.10.1148/radiology.182.1.13092141309214]Search in Google Scholar
[16. Karahan OI, Yikilmaz A, Artis T, Canoz O, Coskun A, Torun E. Contrast-enhanced dynamic magnetic resonance imaging findings of hepatocellular carcinoma and their correlation with histopathologic findings. Eur J Radiol. 2006; 57:445-52.10.1016/j.ejrad.2005.10.00816337762]Open DOISearch in Google Scholar
[17. Singcharoen T, Udompanich O, Chakkapak K. Hepatocellular carcinoma: MR imaging. Australas Radiol. 1992; 36:34-6.10.1111/j.1440-1673.1992.tb03070.x1321597]Search in Google Scholar
[18. Ito K. Hepatocellular carcinoma: conventional MRI findings including gadolinium-enhanced dynamic imaging. Eur J Radiol. 2006; 58:186-99.10.1016/j.ejrad.2005.11.03916413154]Open DOISearch in Google Scholar
[19. Choi BI, Lee GK, Kim ST, Han MC. Mosaic pattern of encapsulated hepatocellular carcinoma: Correlation of magnetic resonance imaging and pathology. Gastrointest Radiol. 1990; 15:238-40.10.1007/BF018887842160392]Open DOISearch in Google Scholar
[20. Jonas S, Bechstein WO, Steinmuller T, Herrmann M, Radke C, Berg T et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology. 2001; 33:1080-6.10.1053/jhep.2001.2356111343235]Search in Google Scholar
[21. Vajragupta L, Tumkosit M, Brown PL, Wangsuphachart S. Detection of small primary and secondary malignant hepatic tumors with superparamagnetic iron oxideenhanced magnetic resonance imaging. Asian Biomed. 2008; 2:135-9.]Search in Google Scholar